Massimo Pinzani
Overview
Explore the profile of Massimo Pinzani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
207
Citations
9446
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miceli V, Ferrigno P, Centi C, Carcione C, Iannolo G, Agnese V, et al.
Heliyon
. 2025 Mar;
11(4):e42515.
PMID: 40028527
Lung transplantation (LTx) significantly improves outcomes for patients with end-stage respiratory failure. However, primary graft dysfunction (PGD) remains one of the most relevant hurdles. Although PGD is attributed to ischemia-reperfusion...
2.
Thanapirom K, Al-Akkad W, Pelut A, Sadouki Z, Finkel J, Nardi-Hiebl S, et al.
Sci Rep
. 2024 Dec;
14(1):29979.
PMID: 39622899
The correlation between circulating microbes and sepsis as well as proinflammatory diseases is increasingly gaining recognition. However, the detection of microbes' cell-free DNA (cfDNA), which exist at concentrations of a...
3.
Gupta V, Sehrawat T, Pinzani M, Strazzabosco M
Gastroenterology
. 2024 Sep;
PMID: 39251168
A consistent feature of chronic liver diseases and the hallmark of pathologic repair is the so-called "ductular reaction." This is a histologic abnormality characterized by an expansion of dysmorphic cholangiocytes...
4.
Snir T, Greenman R, Aricha R, Frankel M, Lawler J, Saffioti F, et al.
Int J Mol Sci
. 2024 Jun;
25(11).
PMID: 38892228
Primary sclerosing cholangitis (PSC) is a rare, progressive disease, characterized by inflammation and fibrosis of the bile ducts, lacking reliable prognostic biomarkers for disease activity. Machine learning applied to broad...
5.
Mor A, Friedman S, Hashmueli S, Peled A, Pinzani M, Frankel M, et al.
Drug Saf
. 2024 Jun;
47(9):869-881.
PMID: 38822943
Background: Overexpression of C-C motif chemokine ligand 24 (CCL24) is associated with inflammatory and fibrotic diseases, including primary sclerosing cholangitis (PSC), systemic sclerosis, metabolic dysfunction-associated steatotic liver disease (MASLD) and...
6.
Papatheodoridi M, de Ledinghen V, Lupsor-Platon M, Bronte F, Boursier J, Elshaarawy O, et al.
J Hepatol
. 2024 May;
81(4):590-599.
PMID: 38789011
Background & Aims: Agile scores, including liver stiffness measurements (LSM) and routine clinical/laboratory biomarkers, have been developed for advanced fibrosis (F≥3) and cirrhosis (F4), respectively, in patients with metabolic dysfunction-associated...
7.
8.
Caon E, Martins M, Hodgetts H, Blanken L, Vilia M, Levi A, et al.
J Hepatol
. 2024 Feb;
80(6):941-956.
PMID: 38365182
Background & Aims: The PNPLA3 rs738409 C>G (encoding for I148M) variant is a risk locus for the fibrogenic progression of chronic liver diseases, a process driven by hepatic stellate cells...
9.
Greenman R, Snir T, Katav A, Aricha R, Mishalian I, Hay O, et al.
Cells
. 2024 Feb;
13(3.
PMID: 38334601
Primary sclerosing cholangitis (PSC) is an inflammatory and fibrotic biliary disease lacking approved treatment. We studied CCL24, a chemokine shown to be overexpressed in damaged bile ducts, and its involvement...
10.
Madir A, Grgurevic I, Tsochatzis E, Pinzani M
World J Gastroenterol
. 2024 Feb;
30(4):290-307.
PMID: 38313235
Portal hypertension (PH) has traditionally been observed as a consequence of significant fibrosis and cirrhosis in advanced non-alcoholic fatty liver disease (NAFLD). However, recent studies have provided evidence that PH...